Trump Accelerates Psychedelic Drug Research to Aid Veterans
Federal policy changes are accelerating psychedelic drug research veterans to improve treatment timelines. This focus on veterans aims to bring MDMA and psilocybin therapies closer to clinical use. The research targets treatment-resistant PTSD and…
Trump Signs Order To Accelerate Legal Access To Psychedelic Therapies For Mental Health
The recent executive order aims to accelerate psychedelic-assisted therapies mental health access, potentially transforming treatment for resistant depression and PTSD. This policy shift could open new pathways for patients who have not responded to…
Largest-Ever Study Finds Medicinal Cannabis Ineffective for Anxiety, Depression, PTSD
A new study reports medicinal cannabis ineffective anxiety depression and PTSD treatment, challenging common perceptions. This finding may influence clinical decision-making and patient counseling. Understanding the study's methodology is crucial before…
Trump Set to Ease Restrictions on Psychedelic Drug for PTSD
Psychedelic drug policy developments are shaping the future of PTSD treatment. Regulatory easing could improve patient access to FDA-approved therapies. Clinicians should monitor these changes closely for clinical implications.
Trump Plans Psychedelic Executive Order (Newsletter: April 17, 2026)
The 2026 psychedelic drug policy developments could reshape access to psilocybin and MDMA treatments currently in FDA trials. These changes matter clinically for patients with PTSD and depression. Clinicians should monitor these developments closely for…
Cannabis May Cause False Memories, Study Finds
False memory formation cannabis effects are a critical safety consideration for users. This study highlights how cannabis may cause individuals to remember events that never happened. Understanding these cannabis memory effects is vital for clinical…
Understanding Alabama Medical Cannabis Qualifying Conditions
Alabama medical cannabis qualifying conditions define who can access treatment under the state's new program. This structured approach ensures patients with chronic pain, PTSD, and other conditions are eligible. Understanding these conditions is key for…
Review Finds Limited Evidence for Cannabis in Treating Mental Health Disorders
A recent review highlights limited evidence cannabis mental health benefits for conditions like PTSD and anxiety. The study emphasizes the need for more rigorous research. Clinicians should consider cannabis as adjunctive, not primary, therapy.
Hawaii Lawmakers Approve Bill To Create Psychedelics Task Force
Hawaii lawmakers have approved a bill to create a psychedelics task force study focused on psilocybin and MDMA. This task force will examine therapeutic applications and regulatory considerations. The study reflects growing interest in psychedelic…
Medicinal Cannabis Demand for Mental Health Soars, Evidence Lags – Monash Lens
Medicinal cannabis mental health demand is rapidly increasing, especially for anxiety and PTSD. However, clinical evidence supporting its use remains limited. This gap creates challenges for healthcare providers balancing patient needs and treatment…